Title |
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients / Claudia Sommerer, Barbara Suwelack, Duska Dragun, Peter Schenker, Ingeborg A. Hauser, Oliver Witzke, Christian Hugo, Nassim Kamar, Pierre Merville, Martina Junge, Friedrich Thaiss, Björn Nashan |
|---|---|
Involved |
Claudia Sommerer (Verfasser)
Barbara Suwelack (Verfasser) Duska Dragun (Verfasser) Peter Schenker (Verfasser)
Ingeborg A. Hauser (Verfasser)
Oliver Witzke (Verfasser) Christian Hugo (Verfasser) Nassim Kamar (Verfasser) Pierre Merville (Verfasser) Martina Junge (Verfasser) Friedrich Thaiss (Verfasser) Björn Nashan (Verfasser) |
Published |
Frankfurt am Main: Universitätsbibliothek Johann Christian Senckenberg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
cyclosporine
efficacy everolimus kidney transplantation
mycophenolate mofetil [MMF]
mycophenolic acid randomized renal function tacrolimus |
DDC notation |
|
Persistent identifier |
|
Further information |
In: Kidney international, 96.2019, Nr. 1, S. 231-244, doi:10.1016/j.kint.2019.01.041 |
Record ID |
1189418088 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: